Heart failure (HF) patients who have reduced or mildly reduced ejection fraction derive better outcomes when low-dose digoxin ...

The drug is derived from the foxglove plant (Digitalis purpurea), which was first described as a treatment for “dropsy” — now ...

Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science session today at Heart Failure 2026, the annual congress of the Heart ...

Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart ...

Placebo-controlled evidence across 9013 patients showed a lower composite risk (HR 0.85) driven by reduced worsening HF events rather than any detectable mortality benefit. Worsening HF events were ...

UB researchers have identified for the first time an enzyme in the foxglove plant that is responsible for the production of compounds needed to make the heart failure drug digoxin. The breakthrough ...

A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, ...

A potentially life threatening label mistake caused Marlex Pharmaceuticals to recall two lots of heart failure medication Digoxin. Here’s what you need to know. What Digoxin tablets are recalled?

After all, in spite of opinion, prejudice or error, Time will fix the real value upon this discovery, and determine whether I have imposed upon myself and others, or contributed to the benefit of ...

Medical topics worthy of writing about transcend the details of the drug or device and implicate a broader lesson. The medical establishment's turn against digoxin perfectly illustrates this duality.